RY5-19009-81803 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-26
Dose 1 — Pfizer-BioNTech
2021-03-16
Registered in v-safe
2021-03-16
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-03-19
Dose 2 — Pfizer-BioNTech
2021-03-21
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-03-26
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-04-02
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-04-09
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-04-30
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-09-17
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-12-30
Dose 3 — Pfizer-BioNTech
2022-03-19
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in
2022-12-30
Survey response — 12 months, dose 3
MedDRA: Nasopharyngitis, Unevaluable event — Feeling: Fair

Free text: Cold, sinus

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-26	Pfizer-BioNTech
2	2021-03-19	Pfizer-BioNTech
3	2021-12-30	Pfizer-BioNTech	No

Free text

Release 12 — 12 months, dose 3

2022-12-30

Symptoms: Cold, sinus

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Nasopharyngitis	·	·	✓
SD	Unevaluable event	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release